Nawi, Nurhana A.

HRN: 23-49-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2026
CEFUROXIME 750MG (VIAL)
04/24/2026
05/01/2026
IV
415MG
Q8
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: